Matthew Redd, DO
Internal Medicine · Ogden, UTNPI 1154642791
Payments from drug & device makers
Across 554 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$888
- Pfizer$608
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$440
- Regeneron Healthcare Solutions, Inc.$402
- plus $2K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 198 | $2,723 |
| Takeda Pharmaceuticals U.S.A., Inc. | 98 | $1,471 |
| Johnson & Johnson | 53 | $888 |
| Pfizer | 71 | $608 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 34 | $440 |
| Regeneron Healthcare Solutions, Inc. | 14 | $402 |
| Bristol Myers Squibb | 12 | $193 |
| QOL Medical, LLC | 9 | $180 |
| Nestle Healthcare Nutrition Inc. | 9 | $159 |
| ERBE USA Inc | 1 | $133 |
| Gilead | 8 | $116 |
| Redhill Biopharma Inc. | 6 | $103 |
| Ardelyx, Inc. | 5 | $96 |
| Sanofi | 5 | $89 |
| Ferring Pharmaceuticals Inc. | 5 | $71 |
| Braintree Laboratories, Inc. | 2 | $46 |
| Merck | 3 | $40 |
| Intercept Pharmaceuticals, Inc. | 3 | $40 |
| Fresenius Kabi USA, LLC | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Organon | 2 | $30 |
| Capsovision, Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $23 |
| Laborie Medical Technologies Corp. | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Biocon Biologics Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$8,104 in reported general payments places this provider in the 90th percentile of 496 internal medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Ogden
- Justin MansfieldOgden$3.1M
- Elena GoncharovaOgden$202K
- Celine RiveraOgden$11K
- Scott MoultonOgden$7K
- Donna MilavetzOgden$7K
- Robert MohrOgden$7K
- Ahad SabetSalt Lake City$34.5M
- Barbara RizzardiSandy$27.8M
- Willard DereSalt Lake City$4.7M
- Joseph WoolleySaint George$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.